Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bernat

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Human Molecular Genetics|April 4, 2014
Functional analysis of candidate genes in 2q13 deletion syndrome implicates FBLN7 and TMEM87B deficiency in congenital heart defects and FBLN7 in craniofacial malformationsMark W Russell, Maide O Raeker, Sarah B Geisler, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1989
Production and evaluation of recombinant hirudinM Courtney, G Loison, Y Lemoine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonistJ M Herbert, A Bernat, G Valette, et al.
Blood|May 30, 1998
Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.
Thrombosis and Haemostasis|October 6, 1998
SR 121787, a new orally active fibrinogen receptor antagonistP Savi, A Badorc, A Lalé, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 15, 2005
[Outcome of tunneled hemodialysis catheters as permanent vascular access]J Hernández-Jaras, H García-Pérez, E Torregrosa, et al.
Analytical Chemistry|July 16, 2024
Ion Mobility-Mass Spectrometry Strategies to Elucidate the Anhydrous Structure of Noncovalent Guest/Host ComplexesJody C May, Emanuel Zlibut, Benjamin K Blakley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 27, 2023
Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry diseaseDerralynn Hughes, Derlis Gonzalez, Gustavo Maegawa, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)M Petitou, P Duchaussoy, G Jaurand, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Human Molecular Genetics|April 4, 2014
Functional analysis of candidate genes in 2q13 deletion syndrome implicates FBLN7 and TMEM87B deficiency in congenital heart defects and FBLN7 in craniofacial malformationsMark W Russell, Maide O Raeker, Sarah B Geisler, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1989
Production and evaluation of recombinant hirudinM Courtney, G Loison, Y Lemoine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonistJ M Herbert, A Bernat, G Valette, et al.
Blood|May 30, 1998
Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.
Thrombosis and Haemostasis|October 6, 1998
SR 121787, a new orally active fibrinogen receptor antagonistP Savi, A Badorc, A Lalé, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 15, 2005
[Outcome of tunneled hemodialysis catheters as permanent vascular access]J Hernández-Jaras, H García-Pérez, E Torregrosa, et al.
Analytical Chemistry|July 16, 2024
Ion Mobility-Mass Spectrometry Strategies to Elucidate the Anhydrous Structure of Noncovalent Guest/Host ComplexesJody C May, Emanuel Zlibut, Benjamin K Blakley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 27, 2023
Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry diseaseDerralynn Hughes, Derlis Gonzalez, Gustavo Maegawa, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)M Petitou, P Duchaussoy, G Jaurand, et al.
Pageof 16